挪威第二原发侵袭性黑色素瘤的发病率及相关因素
结果显示首诊后第一年发病率最高为16.8/1000人年,后降至7.3并稳定;年龄增长和男性与风险增加相关,第二原发灶与首原发灶同部位者占47%。
要点
- 首诊后第一年第二原发侵袭性黑色素瘤发病率为16.8/1000人年,第二年降至7.3后稳定
- 年龄越大,首原发与第二原发间隔中位时间越短
- 男性同部位第二原发黑色素瘤的中位间隔短于女性(12 vs 22个月)
核心结论
- 老年和男性与第二原发侵袭性黑色素瘤风险增加相关,提示对男性尤其50岁以上者首诊后至少3年可考虑加强监测。
主要发现
- 首诊后第一年第二原发侵袭性黑色素瘤发病率为16.8(95%CI 14.9-18.7)/1000人年,第二年降至7.3(95%CI 6.0-8.6)后稳定。
- 首原发与第二原发间隔中位时间随年龄增长而缩短:<40岁为37个月(95%CI 8-49),50-59岁为18个月(95%CI 13-24),≥80岁为11个月(95%CI 7-18)。
- 第二原发灶与首原发灶同部位者占47%(359例),不同部位者占53%(407例)。
- 同部位第二原发黑色素瘤的中位间隔男性为12个月(95%CI 7-19),女性为22个月(95%CI 11-35)。
临床怎么用
- 对首原发侵袭性黑色素瘤患者,尤其老年和男性,首诊后至少3年内可考虑加强随访监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients diagnosed with a primary melanoma are at high risk of subsequent melanomas. Understanding the risk of second primary invasive melanoma and associated factors is crucial to optimize patient follow-up. OBJECTIVE: To assess the incidence rate of second primary invasive melanoma and time between the first and second primary invasive melanoma in the Norwegian population. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included data from deidentified records of all invasive melanomas diagnosed in Norway in 2008 to 2020, obtained from the Cancer Registry of Norway. Data were from adults aged 18 years or older diagnosed with a first primary melanoma. Data analysis was performed from March to August 2023. MAIN OUTCOMES AND MEASURES: The main outcome was the incidence rate of second primary invasive melanoma at least 30 days after the first. Accelerated failure time models were fitted to examine potential associations with patient and tumor characteristics. Median time between first and second primary melanomas and 95% CIs were calculated. The likelihood of, and median interval for, second primary melanomas on the same or different site as the first primary were calculated. RESULTS: A total of 19 196 individuals aged 18 years or older were diagnosed with a first primary melanoma. The mean (SD) age at diagnosis of the first primary melanoma was 62 (16) years (range, 18-104 years), and 9763 (51%) were female. The incidence rate in the year following diagnosis was 16.8 (95% CI, 14.9-18.7) per 1000 person-years, which decreased to 7.3 (95% CI, 6.0-8.6) during the second year and stabilized thereafter. Median time between first and second primaries decreased with advancing age and was 37 months (95% CI, 8-49) in patients younger than 40 years, 18 (95% CI, 13-24) in patients aged 50 to 59 years, and 11 (95% CI, 7-18) in patients aged 80 years or older. The second primary was on the same site as their first primary for 47% (359 patients), and on a different site for 53% (407 patients). The median interval until second melanoma on the same site as the initial melanoma was 12 (95% CI, 7-19) months in men and 22 (95% CI, 11-35) months in women. CONCLUSIONS AND RELEVANCE: Older age and male sex were associated with an increased risk, suggesting that increased surveillance intensity may be considered for men, especially those older than 50 years, for at least 3 years after their initial diagnosis, regardless of the characteristics of their first invasive melanoma.
引用
- Ghiasvand R, Green AC, Veierød MB, et al. Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway. JAMA Dermatol. 2024. PMID: 38416466. doi:10.1001/jamadermatol.2023.6251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。